EU5 Cardiac Rhythm Management Devices Market Outlook to 2036 – Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report Download FREE Resources

Published: April 27, 2026 Report Code: GDME21922CRDB-ST

Select Item

GlobalData’s “EU5 Cardiac Rhythm Management Devices Outlook to 2036” is a comprehensive databook report, covering key market data on the EU5 Cardiac Rhythm Management Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers

The EU5 Cardiac Rhythm Management Devices Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
• 2025 company share data for Cardiac Rhythm Management Devices Market.
• Global corporate-level profiles of key companies operating within the EU5 Cardiac Rhythm Management Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

EU5 Cardiac Rhythm Management Devices is segmented as follows:

• Cardiac Resynchronisation Therapy (CRT)

• Implantable Cardioverter Defibrillators (ICD)

• Pacemakers

Reasons to Buy

The EU5 Cardiac Rhythm Management Devices Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

Table of Contents

List of Tables

List of Figures

1 Introduction

1.1 What Is This Report About?

1.2 Cardiac Rhythm Management Devices Market Segmentation

1.3 Definitions of Markets Covered in the Report

2 Cardiac Rhythm Management Devices Market, EU5

2.1 Cardiac Rhythm Management Devices Market, EU5, Revenue ($m), 2024-2036

2.2 Cardiac Rhythm Management Devices Market, EU5, Revenue ($m), 2024-2036

2.3 Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036

2.4 Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036

2.5 Cardiac Rhythm Management Devices Market, EU5, Company Share by Revenue ($m), 2025

3 Cardiac Rhythm Management Devices Market, France

3.1 Cardiac Rhythm Management Devices Market, France, Revenue ($m), 2024-2036

3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, France, Revenue ($m), by Segment, 2024-2036

3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, France, Revenue ($m), by Segment, 2024-2036

3.1.3 Pacemakers Market, France, Revenue ($m), by Segment, 2024-2036

3.2 Cardiac Rhythm Management Devices Market, France, Volume (Units), 2024-2036

3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, France, Volume (Units), by Segment, 2024-2036

3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, France, Volume (Units), by Segment, 2024-2036

3.2.3 Pacemakers Market, France, Volume (Units), by Segment, 2024-2036

3.3 Cardiac Rhythm Management Devices Market, France, Average Price ($), 2024-2036

3.4 Cardiac Rhythm Management Devices Market, France, Company Share by Revenue ($m), 2025

4 Cardiac Rhythm Management Devices Market, Germany

4.1 Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), 2024-2036

4.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Revenue ($m), by Segment, 2024-2036

4.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Revenue ($m), by Segment, 2024-2036

4.1.3 Pacemakers Market, Germany, Revenue ($m), by Segment, 2024-2036

4.2 Cardiac Rhythm Management Devices Market, Germany, Volume (Units), 2024-2036

4.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Germany, Volume (Units), by Segment, 2024-2036

4.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Germany, Volume (Units), by Segment, 2024-2036

4.2.3 Pacemakers Market, Germany, Volume (Units), by Segment, 2024-2036

4.3 Cardiac Rhythm Management Devices Market, Germany, Average Price ($), 2024-2036

4.4 Cardiac Rhythm Management Devices Market, Germany, Company Share by Revenue ($m), 2025

5 Cardiac Rhythm Management Devices Market, Italy

5.1 Cardiac Rhythm Management Devices Market, Italy, Revenue ($m), 2024-2036

5.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Italy, Revenue ($m), by Segment, 2024-2036

5.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Italy, Revenue ($m), by Segment, 2024-2036

5.1.3 Pacemakers Market, Italy, Revenue ($m), by Segment, 2024-2036

5.2 Cardiac Rhythm Management Devices Market, Italy, Volume (Units), 2024-2036

5.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Italy, Volume (Units), by Segment, 2024-2036

5.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Italy, Volume (Units), by Segment, 2024-2036

5.2.3 Pacemakers Market, Italy, Volume (Units), by Segment, 2024-2036

5.3 Cardiac Rhythm Management Devices Market, Italy, Average Price ($), 2024-2036

5.4 Cardiac Rhythm Management Devices Market, Italy, Company Share by Revenue ($m), 2025

6 Cardiac Rhythm Management Devices Market, Spain

6.1 Cardiac Rhythm Management Devices Market, Spain, Revenue ($m), 2024-2036

6.1.1 Cardiac Resynchronisation Therapy (CRT) Market, Spain, Revenue ($m), by Segment, 2024-2036

6.1.2 Implantable Cardioverter Defibrillators (ICD) Market, Spain, Revenue ($m), by Segment, 2024-2036

6.1.3 Pacemakers Market, Spain, Revenue ($m), by Segment, 2024-2036

6.2 Cardiac Rhythm Management Devices Market, Spain, Volume (Units), 2024-2036

6.2.1 Cardiac Resynchronisation Therapy (CRT) Market, Spain, Volume (Units), by Segment, 2024-2036

6.2.2 Implantable Cardioverter Defibrillators (ICD) Market, Spain, Volume (Units), by Segment, 2024-2036

6.2.3 Pacemakers Market, Spain, Volume (Units), by Segment, 2024-2036

6.3 Cardiac Rhythm Management Devices Market, Spain, Average Price ($), 2024-2036

6.4 Cardiac Rhythm Management Devices Market, Spain, Company Share by Revenue ($m), 2025

7 Cardiac Rhythm Management Devices Market, United Kingdom

7.1 Cardiac Rhythm Management Devices Market, United Kingdom, Revenue ($m), 2024-2036

7.1.1 Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), by Segment, 2024-2036

7.1.2 Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), by Segment, 2024-2036

7.1.3 Pacemakers Market, United Kingdom, Revenue ($m), by Segment, 2024-2036

7.2 Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2024-2036

7.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), by Segment, 2024-2036

7.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), by Segment, 2024-2036

7.2.3 Pacemakers Market, United Kingdom, Volume (Units), by Segment, 2024-2036

7.3 Cardiac Rhythm Management Devices Market, United Kingdom, Average Price ($), 2024-2036

7.4 Cardiac Rhythm Management Devices Market, United Kingdom, Company Share by Revenue ($m), 2025

8 Cardiac Rhythm Management Devices Market Pipeline Products

8.1 Cardiac Rhythm Management Devices Market Pipeline Products

8.2 Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development

8.3 Cardiac Rhythm Management Devices – Pipeline Products by Segment

8.4 Cardiac Rhythm Management Devices – Pipeline Products by Territory

8.5 Cardiac Rhythm Management Devices – Pipeline Products by Regulatory Path

8.6 Cardiac Rhythm Management Devices – Pipeline Products by Estimated Approval Date

9 Overview of Key Companies in EU5 Cardiac Rhythm Management Devices Market

9.1 Medtronic Plc

9.1.1 Company Overview

9.2 Abbott Laboratories

9.2.1 Company Overview

9.3 Biotronik SE & Co KG

9.3.1 Company Overview

9.4 Boston Scientific Corp

9.4.1 Company Overview

9.5 MicroPort Scientific Corp

9.5.1 Company Overview

10 Recent Developments

10.1 Corporate Communications

10.1.1 Nov 21, 2025: Advances in Heart Failure Diagnosis Using AI Algorithms

10.1.2 Nov 18, 2025: Startup Consortium Secures €1.7M Government Investment

10.1.3 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System

10.1.4 Nov 13, 2025: Angelini Ventures Opens First Asia Office to Enhance Singapore Biotech Ecosystem

10.1.5 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

10.1.6 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial

10.1.7 Sep 30, 2025: OUI Marks UCSF Silver Anniversary With Almost £3 Billion Raised By Spinouts

10.1.8 Sep 10, 2025: Biotronik Launches Solia CSP S To Simplify Conduction System Pacing Procedures

10.1.9 Aug 19, 2025: Medtronic Appoints John Groetelaars and Bill Jellison as Independent Directors

10.1.10 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed

10.1.11 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio

10.2 Financial Announcements

10.2.1 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results

10.2.2 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results

10.2.3 May 07, 2025: Medtronic to Announce Financial Results for Its Fourth Quarter and Full Fiscal Year 2025

10.3 Government and Public Interest

10.3.1 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium

10.3.2 Aug 29, 2025: Medtronic Executives to Speak at Upcoming Investor Conferences

10.3.3 Aug 22, 2025: LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September

10.3.4 May 23, 2025: Medtronic Chairman and CEO Geoff Martha to Speak at Bernstein's Strategic Decisions Conference

10.4 Legal And Regulatory

10.4.1 Oct 17, 2025: Acarix Responds to G-BA Decision on Reimbursement in the German Market

10.5 Other Significant Developments

10.5.1 Nov 18, 2025: Startup Consortium Secures €1.7M Government Investment

10.5.2 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results

10.5.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

10.5.4 Oct 17, 2025: Acarix Responds to G-BA Decision on Reimbursement in the German Market

10.5.5 Oct 17, 2025: New Value Based Procurement Guidelines Launched

10.5.6 Oct 14, 2025: Conformal Medical Begins First Patient Enrollment in E.U. for CONFORM Pivotal Trial

10.5.7 Oct 06, 2025: Implantica Completes MDSAP Recertification Audit

10.5.8 Sep 26, 2025: Government Invests Over €33 Million In Eight DTIF Projects

10.5.9 Sep 26, 2025: Health Minister Supports Barts Health Breakthrough

10.5.10 Sep 18, 2025: Ochsner Health Introduces AI Technology For Atrial Fibrillation Treatment

10.6 Product News

10.6.1 Dec 01, 2025: Catheter Precision Launches LockeT in Switzerland

10.6.2 Nov 21, 2025: Advances in Heart Failure Diagnosis Using AI Algorithms

10.6.3 Nov 19, 2025: Canon Medical Systems USA Introduces Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, Now FDA Cleared

10.6.4 Nov 19, 2025: BeGraft Plus CE-Approved for Use as BEVAR Bridging Stent

10.6.5 Nov 18, 2025: Startup Consortium Secures €1.7M Government Investment

10.6.6 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System

10.6.7 Nov 17, 2025: Terumo Aortic Launches Fenestrated TREO Pivotal IDE Study in the United States

10.6.8 Nov 09, 2025: Uz Brussel Achieves 500 Procedures With Affera System for Heart Rhythm Disorders

10.6.9 Nov 05, 2025: Fluid Control Solutions For MedTech

10.6.10 Oct 30, 2025: Humacyte Publishes New Data Comparing Symvess to Autologous Vein in Extremity Arterial Trauma

10.6.11 Oct 28, 2025: Medicalgorithmics And Lund University Collaborate On AI Initiative For Cardiac Function Dataset

10.6.12 Oct 23, 2025: Emboline, Inc. Completes Enrollment in U.S. Pivotal IDE Trial of the Emboliner Embolic Protection Catheter

10.6.13 Oct 22, 2025: Norav Medical Launches TeleEVENT – Full Disclosure Event Recorder for Remote Cardiac Telemetry

10.6.14 Oct 15, 2025: Anteris Secures European Approval to Launch DurAVR® THV Global Pivotal Trial

10.6.15 Oct 14, 2025: Conformal Medical Begins First Patient Enrollment in E.U. for CONFORM Pivotal Trial

10.6.16 Oct 06, 2025: Implantica Completes MDSAP Recertification Audit

10.6.17 Sep 30, 2025: Sequana Medical Features Alfapump System at 2025 Portal Intervention Symposium

10.6.18 Sep 20, 2025: Zenicor Integrates Advanced AI for Arrhythmia Diagnostics

10.6.19 Sep 18, 2025: Argá Medtech Announces First Enrollments in COHERENT-AF Clinical Trial

10.6.20 Sep 18, 2025: Ochsner Health Introduces AI Technology For Atrial Fibrillation Treatment

10.6.21 Sep 11, 2025: Tricorder Study Proves AI Enhances Heart Disease Detection

10.6.22 Sep 09, 2025: Neurescue Device Receives CE Mark Approval for Non-Shockable Cardiac Arrest Treatment

10.7 Strategy And Business Planning

10.7.1 Dec 01, 2025: Catheter Precision Launches LockeT in Switzerland

10.7.2 Nov 20, 2025: New Propelus Prototype Centers

10.7.3 Nov 13, 2025: Angelini Ventures Opens First Asia Office to Enhance Singapore Biotech Ecosystem

10.7.4 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

10.7.5 Oct 28, 2025: Medicalgorithmics And Lund University Collaborate On AI Initiative For Cardiac Function Dataset

10.7.6 Oct 23, 2025: Biotronik And University Of Sydney Collaborate To Enhance Cardiac Care Through Digital Innovation

10.7.7 Sep 30, 2025: Icentia Reduces Inventory Time by 66% with Odoo

10.7.8 Sep 25, 2025: Philips Joins Optum Healthcare Network as Preferred Provider

10.7.9 Sep 18, 2025: Argá Medtech Announces First Enrollments in COHERENT-AF Clinical Trial

10.7.10 Sep 11, 2025: Tricorder Study Proves AI Enhances Heart Disease Detection

11 Appendix

11.1 Research Methodology

11.1.1 Coverage

11.1.2 Secondary Research

11.1.3 Primary Research

11.1.4 Market Modeling and Forecasting

11.1.5 Company Share Analysis

11.1.6 Benchmarking

11.2 GlobalData Consulting

11.3 Contact Us

11.4 Disclaimer

Table

Table 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2024-2036

Table 2: Cardiac Rhythm Management Devices Market, EU5, Revenue ($m), USD Constant, 2024-2036

Table 3: Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036

Table 4: Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036

Table 5: Cardiac Rhythm Management Devices Market, EU5, Company Share by Revenue ($m), 2025

Table 6: Cardiac Rhythm Management Devices Market, France, Revenue ($m), USD Constant, 2024-2036

Table 7: Cardiac Resynchronisation Therapy (CRT) Market, France, Revenue ($m), USD Constant, 2024-2036

Table 8: Implantable Cardioverter Defibrillators (ICD) Market, France, Revenue ($m), USD Constant, 2024-2036

Table 9: Pacemakers Market, France, Revenue ($m), USD Constant, 2024-2036

Table 10: Cardiac Rhythm Management Devices Market, France, Volume (Units), 2024-2036

Table 11: Cardiac Resynchronisation Therapy (CRT) Market, France, Volume (Units), 2024-2036

Table 12: Implantable Cardioverter Defibrillators (ICD) Market, France, Volume (Units), 2024-2036

Table 13: Pacemakers Market, France, Volume (Units), 2024-2036

Table 14: Cardiac Rhythm Management Devices Market, France, Average Price ($), 2024-2036

Table 15: Cardiac Rhythm Management Devices Market, France, Company Share by Revenue ($m), USD Constant, 2025

Table 16: Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), USD Constant, 2024-2036

Table 17: Cardiac Resynchronisation Therapy (CRT) Market, Germany, Revenue ($m), USD Constant, 2024-2036

Table 18: Implantable Cardioverter Defibrillators (ICD) Market, Germany, Revenue ($m), USD Constant, 2024-2036

Table 19: Pacemakers Market, Germany, Revenue ($m), USD Constant, 2024-2036

Table 20: Cardiac Rhythm Management Devices Market, Germany, Volume (Units), 2024-2036

Table 21: Cardiac Resynchronisation Therapy (CRT) Market, Germany, Volume (Units), 2024-2036

Table 22: Implantable Cardioverter Defibrillators (ICD) Market, Germany, Volume (Units), 2024-2036

Table 23: Pacemakers Market, Germany, Volume (Units), 2024-2036

Table 24: Cardiac Rhythm Management Devices Market, Germany, Average Price ($), 2024-2036

Table 25: Cardiac Rhythm Management Devices Market, Germany, Company Share by Revenue ($m), USD Constant, 2025

Table 26: Cardiac Rhythm Management Devices Market, Italy, Revenue ($m), USD Constant, 2024-2036

Table 27: Cardiac Resynchronisation Therapy (CRT) Market, Italy, Revenue ($m), USD Constant, 2024-2036

Table 28: Implantable Cardioverter Defibrillators (ICD) Market, Italy, Revenue ($m), USD Constant, 2024-2036

Table 29: Pacemakers Market, Italy, Revenue ($m), USD Constant, 2024-2036

Table 30: Cardiac Rhythm Management Devices Market, Italy, Volume (Units), 2024-2036

Table 31: Cardiac Resynchronisation Therapy (CRT) Market, Italy, Volume (Units), 2024-2036

Table 32: Implantable Cardioverter Defibrillators (ICD) Market, Italy, Volume (Units), 2024-2036

Table 33: Pacemakers Market, Italy, Volume (Units), 2024-2036

Table 34: Cardiac Rhythm Management Devices Market, Italy, Average Price ($), 2024-2036

Table 35: Cardiac Rhythm Management Devices Market, Italy, Company Share by Revenue ($m), USD Constant, 2025

Table 36: Cardiac Rhythm Management Devices Market, Spain, Revenue ($m), USD Constant, 2024-2036

Table 37: Cardiac Resynchronisation Therapy (CRT) Market, Spain, Revenue ($m), USD Constant, 2024-2036

Table 38: Implantable Cardioverter Defibrillators (ICD) Market, Spain, Revenue ($m), USD Constant, 2024-2036

Table 39: Pacemakers Market, Spain, Revenue ($m), USD Constant, 2024-2036

Table 40: Cardiac Rhythm Management Devices Market, Spain, Volume (Units), 2024-2036

Table 41: Cardiac Resynchronisation Therapy (CRT) Market, Spain, Volume (Units), 2024-2036

Table 42: Implantable Cardioverter Defibrillators (ICD) Market, Spain, Volume (Units), 2024-2036

Table 43: Pacemakers Market, Spain, Volume (Units), 2024-2036

Table 44: Cardiac Rhythm Management Devices Market, Spain, Average Price ($), 2024-2036

Table 45: Cardiac Rhythm Management Devices Market, Spain, Company Share by Revenue ($m), USD Constant, 2025

Table 46: Cardiac Rhythm Management Devices Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036

Table 47: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036

Table 48: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036

Table 49: Pacemakers Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036

Table 50: Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2024-2036

Table 51: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), 2024-2036

Table 52: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), 2024-2036

Table 53: Pacemakers Market, United Kingdom, Volume (Units), 2024-2036

Table 54: Cardiac Rhythm Management Devices Market, United Kingdom, Average Price ($), 2024-2036

Table 55: Cardiac Rhythm Management Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2025

Table 56: Cardiac Rhythm Management Devices Market Pipeline Products

Table 57: Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development

Table 58: Cardiac Rhythm Management Devices Companies – Pipeline Products by Stage of Development

Table 59: Cardiac Rhythm Management Devices – Pipeline Products by Segment

Table 60: Cardiac Rhythm Management Devices – Pipeline Products by Territory

Table 61: Cardiac Rhythm Management Devices – Pipeline Products by Regulatory Path

Table 62: Cardiac Rhythm Management Devices – Pipeline Products by Estimated Approval Date

Table 63: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country

Figures

Figure 1: Cardiac Rhythm Management Devices Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2024-2036

Figure 2: Cardiac Rhythm Management Devices Market, EU5, Revenue ($m), USD Constant, 2024-2036

Figure 3: Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036

Figure 4: Cardiac Rhythm Management Devices Market, EU5, Volume (Units), 2024-2036

Figure 5: Cardiac Rhythm Management Devices Market, EU5, Company Share (%), 2025

Figure 6: Cardiac Rhythm Management Devices Market, France, Revenue ($m), USD Constant, 2024-2036

Figure 7: Cardiac Resynchronisation Therapy (CRT) Market, France, Revenue ($m), USD Constant, 2024-2036

Figure 8: Implantable Cardioverter Defibrillators (ICD) Market, France, Revenue ($m), USD Constant, 2024-2036

Figure 9: Pacemakers Market, France, Revenue ($m), USD Constant, 2024-2036

Figure 10: Cardiac Rhythm Management Devices Market, France, Volume (Units), 2024-2036

Figure 11: Cardiac Resynchronisation Therapy (CRT) Market, France, Volume (Units), 2024-2036

Figure 12: Implantable Cardioverter Defibrillators (ICD) Market, France, Volume (Units), 2024-2036

Figure 13: Pacemakers Market, France, Volume (Units), 2024-2036

Figure 14: Cardiac Rhythm Management Devices Market, France, Company Share (%), 2025

Figure 15: Cardiac Rhythm Management Devices Market, Germany, Revenue ($m), USD Constant, 2024-2036

Figure 16: Cardiac Resynchronisation Therapy (CRT) Market, Germany, Revenue ($m), USD Constant, 2024-2036

Figure 17: Implantable Cardioverter Defibrillators (ICD) Market, Germany, Revenue ($m), USD Constant, 2024-2036

Figure 18: Pacemakers Market, Germany, Revenue ($m), USD Constant, 2024-2036

Figure 19: Cardiac Rhythm Management Devices Market, Germany, Volume (Units), 2024-2036

Figure 20: Cardiac Resynchronisation Therapy (CRT) Market, Germany, Volume (Units), 2024-2036

Figure 21: Implantable Cardioverter Defibrillators (ICD) Market, Germany, Volume (Units), 2024-2036

Figure 22: Pacemakers Market, Germany, Volume (Units), 2024-2036

Figure 23: Cardiac Rhythm Management Devices Market, Germany, Company Share (%), 2025

Figure 24: Cardiac Rhythm Management Devices Market, Italy, Revenue ($m), USD Constant, 2024-2036

Figure 25: Cardiac Resynchronisation Therapy (CRT) Market, Italy, Revenue ($m), USD Constant, 2024-2036

Figure 26: Implantable Cardioverter Defibrillators (ICD) Market, Italy, Revenue ($m), USD Constant, 2024-2036

Figure 27: Pacemakers Market, Italy, Revenue ($m), USD Constant, 2024-2036

Figure 28: Cardiac Rhythm Management Devices Market, Italy, Volume (Units), 2024-2036

Figure 29: Cardiac Resynchronisation Therapy (CRT) Market, Italy, Volume (Units), 2024-2036

Figure 30: Implantable Cardioverter Defibrillators (ICD) Market, Italy, Volume (Units), 2024-2036

Figure 31: Pacemakers Market, Italy, Volume (Units), 2024-2036

Figure 32: Cardiac Rhythm Management Devices Market, Italy, Company Share (%), 2025

Figure 33: Cardiac Rhythm Management Devices Market, Spain, Revenue ($m), USD Constant, 2024-2036

Figure 34: Cardiac Resynchronisation Therapy (CRT) Market, Spain, Revenue ($m), USD Constant, 2024-2036

Figure 35: Implantable Cardioverter Defibrillators (ICD) Market, Spain, Revenue ($m), USD Constant, 2024-2036

Figure 36: Pacemakers Market, Spain, Revenue ($m), USD Constant, 2024-2036

Figure 37: Cardiac Rhythm Management Devices Market, Spain, Volume (Units), 2024-2036

Figure 38: Cardiac Resynchronisation Therapy (CRT) Market, Spain, Volume (Units), 2024-2036

Figure 39: Implantable Cardioverter Defibrillators (ICD) Market, Spain, Volume (Units), 2024-2036

Figure 40: Pacemakers Market, Spain, Volume (Units), 2024-2036

Figure 41: Cardiac Rhythm Management Devices Market, Spain, Company Share (%), 2025

Figure 42: Cardiac Rhythm Management Devices Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036

Figure 43: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036

Figure 44: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036

Figure 45: Pacemakers Market, United Kingdom, Revenue ($m), USD Constant, 2024-2036

Figure 46: Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2024-2036

Figure 47: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), 2024-2036

Figure 48: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), 2024-2036

Figure 49: Pacemakers Market, United Kingdom, Volume (Units), 2024-2036

Figure 50: Cardiac Rhythm Management Devices Market, United Kingdom, Company Share (%), 2025

Figure 51: Cardiac Rhythm Management Devices – Pipeline Products by Stage of Development

Figure 52: Cardiac Rhythm Management Devices – Pipeline Products by Segment

Figure 53: Cardiac Rhythm Management Devices – Pipeline Products by Territory

Figure 54: Cardiac Rhythm Management Devices – Pipeline Products by Regulatory Path

Figure 55: Cardiac Rhythm Management Devices – Pipeline Products by Estimated Approval Date

EU5 Cardiac Rhythm Management Devices Market Outlook to 2036 – Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

EU5 Cardiac Rhythm Management Devices Market Outlook to 2036 – Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Cardiovascular Devices reports
Medical Devices
New
Sutures Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and…
$7,500 | June 2026
Medical Devices
New
Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Medical Devices
New
Neurovascular Accessory Devices Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at EU5 Cardiac Rhythm Management Devices Market Outlook to 2036 – Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers in real time.

  • Access a live EU5 Cardiac Rhythm Management Devices Market Outlook to 2036 – Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more